Janus Henderson Group PLC Charles River Laboratories International, Inc. Transaction History

Janus Henderson Group PLC

  • $194 Billion
  • Q2 2025

A detailed history of Janus Henderson Group PLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 23,655 shares of CRL stock, worth $4.62 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,655
Previous 24,203 2.26%
Holding current value
$4.62 Million
Previous $3.64 Million 1.48%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
$99.75 - $151.89 $54,663 - $83,235
-548 Reduced 2.26%
23,655 $3.59 Million
Q1 2025

May 15, 2025
SELL
$150.52 - $190.14 $4.83 Million - $6.1 Million
-32,085 Reduced 57.0%
24,203 $3.64 Million
Q4 2024

Feb 14, 2025
BUY
$178.58 - $220.69 $1.83 Million - $2.27 Million
10,270 Added 22.32%
56,288 $10.4 Million
Q3 2024

Nov 14, 2024
BUY
$187.96 - $245.29 $614,253 - $801,607
3,268 Added 7.64%
46,018 $9.07 Million
Q2 2024

Aug 14, 2024
SELL
$206.39 - $268.73 $788,616 - $1.03 Million
-3,821 Reduced 8.2%
42,750 $8.83 Million
Q1 2024

May 15, 2024
SELL
$203.52 - $273.43 $6.71 Million - $9.01 Million
-32,964 Reduced 41.45%
46,571 $12.6 Million
Q4 2023

Feb 14, 2024
BUY
$164.52 - $238.84 $1.41 Million - $2.04 Million
8,555 Added 12.05%
79,535 $18.8 Million
Q3 2023

Nov 14, 2023
SELL
$194.44 - $217.61 $3.38 Million - $3.78 Million
-17,369 Reduced 19.66%
70,980 $13.9 Million
Q2 2023

Aug 14, 2023
SELL
$183.71 - $210.25 $4.72 Million - $5.41 Million
-25,713 Reduced 22.54%
88,349 $18.6 Million
Q1 2023

May 15, 2023
BUY
$191.89 - $259.92 $8.71 Million - $11.8 Million
45,383 Added 66.08%
114,062 $23 Million
Q4 2022

Feb 14, 2023
BUY
$197.11 - $250.07 $13.5 Million - $17.2 Million
68,679 New
68,679 $15 Million
Q3 2022

Nov 14, 2022
SELL
$182.44 - $250.54 $124,059 - $170,367
-680 Reduced 14.02%
4,171 $822,000
Q2 2022

Aug 15, 2022
SELL
$204.13 - $302.4 $2 Million - $2.97 Million
-9,822 Reduced 66.94%
4,851 $1.04 Million
Q1 2022

May 16, 2022
BUY
$255.51 - $362.11 $2.15 Million - $3.05 Million
8,421 Added 134.69%
14,673 $4.17 Million
Q4 2021

Feb 14, 2022
BUY
$351.38 - $448.68 $44,625 - $56,982
127 Added 2.07%
6,252 $2.36 Million
Q3 2021

Nov 16, 2021
SELL
$372.64 - $458.3 $4.28 Million - $5.27 Million
-11,489 Reduced 65.23%
6,125 $2.53 Million
Q2 2021

Aug 16, 2021
BUY
$294.17 - $371.65 $5.18 Million - $6.55 Million
17,614 New
17,614 $6.52 Million
Q1 2020

May 14, 2020
SELL
$98.9 - $178.34 $1.23 Million - $2.21 Million
-12,399 Closed
0 $0
Q4 2019

Feb 18, 2020
SELL
$126.05 - $152.76 $2.64 Million - $3.2 Million
-20,968 Reduced 62.84%
12,399 $1.89 Million
Q3 2019

Nov 14, 2019
SELL
$125.07 - $143.67 $4.67 Million - $5.36 Million
-37,309 Reduced 52.79%
33,367 $4.42 Million
Q2 2019

Jul 31, 2019
BUY
$123.4 - $148.55 $2.5 Million - $3.01 Million
20,293 Added 40.28%
70,676 $10 Million
Q1 2019

Apr 30, 2019
SELL
$104.82 - $146.73 $3.22 Million - $4.5 Million
-30,682 Reduced 37.85%
50,383 $7.32 Million
Q4 2018

Feb 06, 2019
BUY
$105.09 - $137.23 $3.21 Million - $4.19 Million
30,565 Added 60.52%
81,065 $9.18 Million
Q3 2018

Nov 09, 2018
BUY
$112.11 - $134.54 $571,761 - $686,154
5,100 Added 11.23%
50,500 $6.79 Million
Q2 2018

Aug 10, 2018
SELL
$102.37 - $117.25 $1.1 Million - $1.25 Million
-10,700 Reduced 19.07%
45,400 $5.1 Million
Q1 2018

May 14, 2018
BUY
$98.19 - $115.2 $490,950 - $576,000
5,000 Added 9.78%
56,100 $5.99 Million
Q4 2017

Feb 09, 2018
BUY
$100.43 - $118.09 $4.71 Million - $5.54 Million
46,900 Added 1116.67%
51,100 $5.59 Million
Q3 2017

Nov 14, 2017
BUY
$96.72 - $109.26 $406,224 - $458,892
4,200
4,200 $0

Others Institutions Holding CRL

# of Institutions
632
Shares Held
52.7M
Call Options Held
1.42M
Put Options Held
1.42M
View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL Quotes by TradingView
  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.93B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email